Feeding Obese Diabetic Mice a Genistein Diet Induces Thermogenic and Metabolic Change

Journal of Medicinal Food

Volumn 21, Issue 4, 2018, Pages 332-339

  Rockwood, Schuyler ^a   Broderick, Tom L ^b   Al Nakkash, Layla ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

11 hydroxysteroid dehydrogenase; genistein; ob ob mouse; obesity; thyroid hormones

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTICOSTERONE; GENISTEIN; INSULIN; ISOFLAVONE; LIOTHYRONINE; GLUCOCORTICOID; PLANT EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; ENERGY EXPENDITURE; FEEDING; FOOD INTAKE; INSULIN METABOLISM; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BLOOD; CHEMISTRY; DIET THERAPY; DRUG EFFECT; EATING; ENERGY METABOLISM; INSULIN RESISTANCE; KIDNEY; KNOCKOUT MOUSE; LIVER; METABOLISM; MOUSE MUTANT; SOYBEAN; THERMOGENESIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CORTICOSTERONE; EATING; ENERGY METABOLISM; GENISTEIN; GLUCOCORTICOIDS; INSULIN RESISTANCE; KIDNEY; LIVER; MALE; MICE, KNOCKOUT; MICE, OBESE; OBESITY; PLANT EXTRACTS; SOYBEANS; THERMOGENESIS; TRIIODOTHYRONINE;

EID: 85045218531     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2017.0084     Document Type: Article

References (44)

1. Despres JP: Physical activity, sedentary behaviours, and cardiovascular health: When will cardiorespiratory fitness become a vital sign? Can J Cardiol 2016;32:505-513.
2. Ravona-Springer R, Schnaider-Beeri M: The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother 2011;11:1609-1617.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
5. Murphy PA, Farmakalidis E, Johnson LD: Isoflavone content of soya-based laboratory animal diets. Food Chem Toxicol 1982;20: 315-317.
6. Ding M, Pan A, Manson JE, et al.: Consumption of soy foods and isoflavones and risk of type 2 diabetes: A pooled analysis of three US cohorts. Eur J Clin Nutr 2016;70:1381-1387.
7. Nguyen CT, Pham NM, Do VV, et al.: Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults. Eur J Clin Nutr 2017;71:1186-1192.
8. Squadrito F, Marini H, Bitto A, et al.: Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab 2017;98:3366-3374.
9. Kavoosi F, Dastjerdi MN, Valiani A, Esfandiari E, Sanaei M, Hakemi MG: Genistein potentiates the effect of 17-beta estradiol on human hepatocellular carcinoma cell line. Adv Biomed Res 2016;5:133.
10. Getek M, Czech N, Muc-Wierzgori M, Grochowska-Niedworok E, Kotok T, Nowakowska-Zajdel E: The active role of leguminous plant components in type 2 diabetes. Evid Based Complement Alternat Med 2014;2014:Article ID 293961.
11. Odle B, Dennison N, Al-Nakkash L, Broderick TL, Plochocki JH: Genistein treatment improves fracture resistance in obese diabetic mice. BMC Endocr Disord 2017;17:1-8.
12. Al-Nakkash L, Marcus B, Bowden K, Batia LM, Prozialeck WC, Broderick TL: Effects of acute and 2-day genistein treatment on cardiac function and ischemic tolerance in ovariectomized rats. Gend Med 2009;6:488-497.
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
14. Hegyi K, Fulop K, Kovacs K, Toth S, Falus A: Leptin-induced signal transduction pathways. Cell Biol Int 2004;28:159-169.
15. Lutz TA, Woods SC: Overview of animal models of obesity. Curr Protoc Pharmacol 2012;Chapter 5:Unit 61.
16. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis. J Clin Endocrinol Metab 2009;94:2692-2701.
17. Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK: Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 2008; 24:74-81.
18. Kim MJ, Lim Y: Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage. Mediators Inflamm 2013;2013:Article ID 510212.
19. Cederroth CR, Vinciquerra M, Gjinovci A, et al.: Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 2008;57: 1176-1185.
20. Ohtake M, Bray GA, Azukizawa M: Studies on hypothermia and thyroid function in the obese (ob/ob) mouse. Am J Physiol 1977; 233:R110-R115.
21. Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ: Dietary genistein stimulates anion secretion across female murine intestine. J Nutr 2006;136:2785-2790.
22. Leung L, Kang J, Rayyan E, et al.: Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice. Diabetes Metab Syndr Obes 2014;7: 321-330.
23. Harms M, Seale P: Brown and beige fat: Development, function and therapeutic potential. Nat Med 2013;19:1252-1263.
24. Otsuki M, Kitamura T, Tamada D, et al.: Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome. Endocr J 2016;63:1017-1023.
25. Sajan MP, Ivey RA, Lee MC, Farese RV: Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation. J Lipid Res 2015;56:70-80.
26. Roden M, Ludwig C, Nowotny P, et al.: Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2000;24:976-981.
27. Mayer J, Barrnett RJ: Sensitivity to cold in the hereditary obesehyperglycemic syndrome of mice. Yale J Biol Med 1953;26:38-45.
28. Bray GA, York DA: Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis. Physiol Rev 1979;59:719-809.
29. Kaiyala KJ, Ogimoto K, Nelson JT, Muta K, Morton GJ: Physiological role for leptin in the control of thermal conductance. Mol Metab 2016;5:892-902.
30. Aziz SA, Wakeling LA, Miwa S, Alberdi G, Hesketh JE, Ford D: Metabolic programming of a beige adipocyte phenotype by genistein. Mol Nutr Food Res 2017;61:Article ID 1600574.
31. Lee J-Y, Takahashi N, Yasubuchi M, et al.: Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes. Am J Physiol Cell 2012;302:C463-C472.
32. Naeser P: Disappearance of 3 h-corticosterone from the serum of obese-hyperglycemic mice (gene symbol ob). Acta Physiol Scand 1975;93:10-14.
33. Livingstone DEW, Jones GC, Smith K, et al.: Understanding the role of glucocorticoids in obesity: Tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-563.
34. Kaminska B, Czerwinska J, Wojciechowicz B, Nynca A, Ciereszko R: Genistein and daidzein affect in vitro steroidogenesis but not gene expression of steroidogenic enzymes in adrenals of pigs. J Physiol Pharmacol 2014;65:127-133.
35. Mesiano S, Katz S, Lee JY, Jaffe RB: Phytoestrogens alter adrenocortical function: Genistein and daidzein suppress glucocorticoid and stimulate androgen production by cultured adrenal cortical cells. J Clin Endocrinol Metab 1999;84:2443-2448.
36. Ajdzanovic V, Sosic-Jurjevic B, Filipovic B, et al.: Genisteininduced histomorphometric and hormone secreting changes in the adrenal cortex in middle-aged rats. Exp Biol Med 2009;234: 148-156.
37. Bailey MA, Craigie E, Livingstone DEW, et al.: Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure. Hypertension 2011;57:515-520.
38. Milagro FI, Campion J, Martinez JA: 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J Steroid Biochem Mol Biol 2007;104:81-84.
39. Mussig K, Remer T, Haupt A, et al.: 11b-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Obesity 2008;16:1256-1260.
40. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect ''Cushing's disease of the omentum''? Lancet 1997;349:1210-1213.
41. Michailidou Z, Jensen MD, Dumesic DA, et al.: Omental 11betahydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity 2007;15:1155-1163.
42. Draper N, Stewart PM: 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 2005;186:251-271.
43. Thamer C, Machann J, Stefan N, et al.: High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity 2017;15:531-538.
44. Liu Y, Nakagawa Y, Wang Y, et al.: Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. Diabetes 2003;52:1409-1416.